Exhibit 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

Avalo Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type									Security Class Title						Fee Calculation Rule						Amount Registered(1)(2)						Proposed Maximum Offering Price Per Share(3)						Maximum Aggregate Offering Price(3)						Fee Rate						Amount of Registration Fee
Equity									Common Stock, $0.001 par value per share						Rules 457(c) and 457(h)(1)						2,122,072						4.6697						$9,909,439.62						$	0.0001531					$1,518
Total Offering Amounts																																													$1,518
Total Fee Offsets																																													$—
Net Fee Due																																													$1,518
(1)			Consists of (i) 1,768,393 additional shares reserved for issuance under the Avalo Therapeutics, Inc. Fourth Amended and Restated 2016 Equity Incentive Plan (the “2016 Stock Plan”) and (ii) 353,679 additional shares reserved for issuance under the Avalo Therapeutics, Inc. 2016 Employee Stock Purchase Plan (the “ESPP”).
(2)			Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional shares of Registrant’s common stock that become issuable under the 2016 Stock Plan by reason of any stock dividend, stock split, recapitalization, or other similar transaction that results in an increase in the number of outstanding shares of the Registrant’s common stock.
(3)			Estimated in accordance with Rules 457(c) and 457(h)(1) of the Securities Act solely for the purpose of calculating the registration fee based upon the average of the high and low prices of the Registrant’s common stock on the NASDAQ Capital Market on May 7, 2025.